hydralazine has been researched along with Raynaud Disease in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kochar, MS | 1 |
| McWeeney, J | 1 |
| Finnegan, P | 1 |
| Russell, IJ | 1 |
| Walsh, RA | 1 |
3 other studies available for hydralazine and Raynaud Disease
| Article | Year |
|---|---|
Simultaneous treatment of Raynaud's phenomenon and orthostatic hypotension.
Topics: Drug Therapy, Combination; Ephedrine; Female; Fludrocortisone; Follow-Up Studies; Humans; Hydralazin | 1983 |
Vasodilator therapy of pulmonary hypertension in the CRST syndrome.
Topics: Calcinosis; Female; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Raynaud Disease | 1982 |
Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.
Topics: Adult; Diltiazem; Female; Humans; Hydralazine; Infusions, Intra-Arterial; Male; Phenoxybenzamine; Pl | 1985 |